Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Myeloperoxidase directs properdin-mediated complement activation.

O'Flynn J, Dixon KO, Faber Krol MC, Daha MR, van Kooten C.

J Innate Immun. 2014;6(4):417-25. doi: 10.1159/000356980. Epub 2013 Dec 20.

PMID:
24355864
2.

Neutrophil extracellular traps can activate alternative complement pathways.

Wang H, Wang C, Zhao MH, Chen M.

Clin Exp Immunol. 2015 Sep;181(3):518-27. doi: 10.1111/cei.12654. Epub 2015 Jun 22.

3.

Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5.

Freeley SJ, Popat RJ, Parmar K, Kolev M, Hunt BJ, Stover CM, Schwaeble W, Kemper C, Robson MG.

J Pathol. 2016 Sep;240(1):61-71. doi: 10.1002/path.4754.

4.

Complement activation by tubular cells is mediated by properdin binding.

Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, Berger SP.

Am J Physiol Renal Physiol. 2008 Nov;295(5):F1397-403. doi: 10.1152/ajprenal.90313.2008. Epub 2008 Aug 27.

PMID:
18753294
5.

Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.

Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM.

MBio. 2011 Aug 30;2(5). pii: e00178-11. doi: 10.1128/mBio.00178-11. Print 2011.

6.
7.

An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Agarwal S, Ferreira VP, Cortes C, Pangburn MK, Rice PA, Ram S.

J Immunol. 2010 Jul 1;185(1):507-16. doi: 10.4049/jimmunol.0903598. Epub 2010 Jun 7.

8.

Properdin homeostasis requires turnover of the alternative complement pathway.

Wu X, Xu TQ, Atkinson JP.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19444-8. doi: 10.1073/pnas.1006608107. Epub 2010 Oct 25. Retraction in: Wu X, Atkinson JP. Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10372.

9.

Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm.

Zhou HF, Yan H, Stover CM, Fernandez TM, Rodriguez de Cordoba S, Song WC, Wu X, Thompson RW, Schwaeble WJ, Atkinson JP, Hourcade DE, Pham CT.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):E415-22. doi: 10.1073/pnas.1119000109. Epub 2012 Jan 30.

10.

Myeloperoxidase influences the complement regulatory function of modified C-reactive protein.

Xu PC, Li ZY, Yang XW, Zhao MH, Chen M.

Innate Immun. 2014 May;20(4):440-8. doi: 10.1177/1753425913508164. Epub 2013 Nov 4.

PMID:
24189124
11.

Complement alternative pathway acts as a positive feedback amplification of neutrophil activation.

Camous L, Roumenina L, Bigot S, Brachemi S, Frémeaux-Bacchi V, Lesavre P, Halbwachs-Mecarelli L.

Blood. 2011 Jan 27;117(4):1340-9. doi: 10.1182/blood-2010-05-283564. Epub 2010 Nov 9.

12.

Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).

Saggu G, Cortes C, Emch HN, Ramirez G, Worth RG, Ferreira VP.

J Immunol. 2013 Jun 15;190(12):6457-67. doi: 10.4049/jimmunol.1300610. Epub 2013 May 15.

13.

Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.

Junker A, Baatrup G, Svehag SE, Wang P, Holmström E, Sturfelt G, Sjöholm AG.

Scand J Immunol. 1998 May;47(5):481-6.

14.

Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies.

Gupta-Bansal R, Parent JB, Brunden KR.

Mol Immunol. 2000 Apr;37(5):191-201.

PMID:
10930626
15.

Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Segers FM, Verdam FJ, de Jonge C, Boonen B, Driessen A, Shiri-Sverdlov R, Bouvy ND, Greve JW, Buurman WA, Rensen SS.

PLoS One. 2014 Oct 9;9(10):e110053. doi: 10.1371/journal.pone.0110053. eCollection 2014.

16.

Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin.

O'Flynn J, van der Pol P, Dixon KO, Prohászka Z, Daha MR, van Kooten C.

Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1308-16. doi: 10.1152/ajprenal.00645.2014. Epub 2016 Mar 16.

PMID:
26984957
17.

NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways.

Yuen J, Pluthero FG, Douda DN, Riedl M, Cherry A, Ulanova M, Kahr WH, Palaniyar N, Licht C.

Front Immunol. 2016 Apr 14;7:137. doi: 10.3389/fimmu.2016.00137. eCollection 2016.

18.
19.

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC.

Am J Pathol. 2007 Jan;170(1):52-64.

20.

The role of properdin in zymosan- and Escherichia coli-induced complement activation.

Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE.

J Immunol. 2012 Sep 1;189(5):2606-13. doi: 10.4049/jimmunol.1200269. Epub 2012 Jul 30.

Supplemental Content

Support Center